Trading volume was 19.9 times its 30-day average, The stock rose 10.2 percent so far this year.
Shares of the drugmaker rose as much as 8.7 percent, the most in over a year, to trade near a two-month high at Rs 2,655.
SELL DRREDDY 5250 TRG 5180-5000-4950 SL PAID – Neal Bhai
Trading volume was 19.9 times its 30-day average, The stock rose 10.2 percent so far this year.
Shares of the drugmaker rose as much as 8.7 percent, the most in over a year, to trade near a two-month high at Rs 2,655.
Dr. Reddy’s Labs Drops On Repeat Observations For Duvvada Plant – Shares of the Hyderabad-based drug maker fell as much as 2.61 percent to Rs 2,389 after it received eight observations, five of them a repeat of 2017 and warning letter of 2015, from the U.S. drug regulator at its Duvvada facility—crucial for future growth prospects in its largest market.
Gold Silver Reports (GSR) – Vedanta Set For Its Longest Losing Streak In Over Three Months – Shares of the metal maker extended its decline for the seventh straight session today, its longest losing streak since March 9. The stock fell as much as 3.3 percent to hit a 52-week low at Rs 230.65 apiece.